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Abstract
Background: Verbal autopsy is important for detecting causes of death including HIV in areas with inadequate
vital registration systems. Before antiretroviral therapy (ART) introduction, a verbal autopsy study in rural Uganda
found that half of adult deaths assessed were in HIV-positive individuals. We used verbal autopsy to compare the
proportion of HIV-positive adult deaths in the periods before and after ART introduction.
Methods: Between 2006 and 2008, all adult (≥ 13 years) deaths in a prospective population-based cohort study
were identified by monthly death registration, and HIV serostatus was determined through annual serosurveys. A
clinical officer interviewed a relative of the deceased using a verbal autopsy questionnaire. Two clinicians
independently reviewed the questionnaires and classified the deaths as HIV-positive or not. A third clinician was
the tie-breaker in case of nonagreement. The performance of the verbal autopsy tool was assessed using HIV
serostatus as the gold standard of comparison. We compared the proportions of HIV-positive deaths as assessed by
verbal autopsy in the early 1990s and the 2006-2008 periods.
Results: Of 333 deaths among 12,641 adults of known HIV serostatus, 264 (79.3%) were assessed by verbal
autopsy, of whom 59 (22.3%) were HIV-seropositive and 68 (25.8%) were classified as HIV-positive by verbal
autopsy. Verbal autopsy had a specificity of 90.2% and positive predictive value of 70.6% for identifying deaths
among HIV-infected individuals, with substantial interobserver agreement (80.3%; kappa statistic = 0.69). The HIV-
attributable mortality fraction estimated by verbal autopsy decreased from 47.0% (pre-ART period) to 25.8% (ART
period), p < 0.001.
Conclusions: In resource-limited settings, verbal autopsy can provide a good estimate of the prevalence of HIV
infection among adult deaths. In this rural population, the proportion of deaths identified by verbal autopsy as HIV-
positive declined between the early 1990s and the 2006-2008 period. Verbal autopsy findings can inform policy on
HIV health care needs.
Background
Most resource-limited settings have inadequate or no
vital registration systems, although many deaths in these
areas occur outside health care facilities and vital regis-
tration data are essential for public health planning
[1,2]. Since 2004, many countries including Uganda
have scaled up access to antiretroviral therapy (ART).
Knowing the impact of ART introduction on the pro-
portion of deaths that are associated with HIV is impor-
tant for policymakers [3,4].
The World Health Organization (WHO) has stimu-
lated interest in the use of verbal autopsy as a tool to
obtain information on causes of death in areas with
inadequate vital registration systems, for public health
planning and resource allocation [5]. In a WHO
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workshop, priority research questions were identified for
the use of verbal autopsy tools in longitudinal popula-
tion-based HIV studies: the accuracy of verbal autopsy
for HIV/AIDS identification, especially in terms of
detecting changes in causes of death over time; the best
verbal autopsy questions to identify HIV infection in
deceased persons; and verbal autopsy questions to be
used for ART-related deaths [6].
From 1990 to 1993, before ART was available in rural
Uganda, the verbal autopsy tool was validated using the
HIV test results obtained from consecutive annual HIV
serosurveys in the same population. Half of the deaths
among adults aged 13 years and above were among
HIV-positive people and the specificity and positive pre-
dictive value of the verbal autopsy tool for identifying
HIV-positive deaths were both 92%. The study methods
and verbal autopsy questionnaire used during this study
have been described in detail before [7].
We designed a study to evaluate the usefulness of ver-
bal autopsy in identifying deaths among adults with HIV
infection after the introduction of ART in 2004 in the
same population. We also compared the proportions of
deaths identified as HIV-positive before and after ART
introduction, by comparing our results to those from
the 1990-1993 verbal autopsy study.
Methods
Study setting and participants
In 1989, a general population cohort (GPC) was estab-
lished in rural southwest Uganda to describe the popula-
tion dynamics of HIV infection. The GPC originally
consisted of around 4,500 adults (aged 13 years and
above) in 15 neighboring villages [8]. In 1999, 10 more
villages were added to the survey area, bringing the total
number of adults to around 14,530 in 2006-2008 [9].
Annual house-to-house census and HIV serosurveys are
conducted. The average annual survey participation is
60% to 65%, although 84% have ever participated in the
HIV serosurvey. In 1990, a clinical cohort nested within
the GPC was established to study the natural history of
HIV infection. The study setting has a stable homoge-
neous population, in which adult HIV prevalence initi-
ally declined from 8.5% in 1990-1991 to 6.2% in 1999-
2000 but then rose to 7.7% in 2004-2005 [10,11]. Since
January 2004, ART has been provided for all eligible
participants at the study clinic according to the Uganda
National ART guidelines [12,13]. At the time of the
study, the population of Uganda was 29.6 million people
with a national average HIV prevalence of 6.4% [14].
Notification of deaths and condolence visit
The GPC study purposely instituted 26 community-
based recorders, who every month collect and report
information on all deaths and births that occur in their
villages in the study area, and this information is
updated by the annual census conducted in the same
cohort. From January 2006 until December 2008, all
deaths that occurred in adults in the study area were
assessed by verbal autopsy. A home visitor paid a con-
dolence visit to relatives of the eligible deceased soon
after the death (usually within one month) and informed
them about the study, giving them opportunity to ask
questions. A copy of the study information sheet was
given to the relatives most closely associated with the
deceased. A verbal autopsy interview appointment was
made (approximately two months after death occurred)
with consenting relatives.
The verbal autopsy visit
The interviewer (a clinical officer) and a home visitor
visited the relative of the deceased on the agreed date
and, after obtaining written informed consent, adminis-
tered a verbal autopsy questionnaire. The verbal autopsy
questionnaire was the same as that validated in 1990-
1993 in the same study area but with additional ques-
tions on ART use (Appendix). The questionnaire was
comparable to the WHO SAVVY (sample vital registra-
tion with verbal autopsy) International verbal autopsy
questionnaire 3 for death of a person aged 15 years and
above. However, it missed some of the questions in Sec-
tion 5: History of previously known medical conditions
(especially high blood pressure, diabetes, asthma, and
cancer), Section 7: Symptoms and signs associated with
illnesses of women, Section 8: Symptoms and signs asso-
ciated with pregnancy, and Section 10: Treatment and
health service use for the final illness.
During the verbal autopsy interview, the respondent
was asked to give a narration of the events preceding
the death and then specific questions were asked on the
symptoms prior to death and whether the deceased was
on ART. At the end of the verbal autopsy interview, the
opinion of the respondent on the deceased’s cause of
death was sought by asking whether the respondent
thought that he/she knew the cause of death. If the
response was ‘yes’, the respondent was asked how or
from whom he/she knew (for example, own opinion,
from another household member, from doctor/nurse
treating the deceased). The interviewer also recorded
what she thought was the cause of death. Each com-
pleted questionnaire was checked for completeness and
consistency by a physician and any queries were dis-
cussed and clarified with the interviewer.
Independent allocation of cause of death
The verbal autopsy questionnaires were independently
reviewed by two experienced physicians (both clinical
epidemiologists) from outside the study area to ascertain
the likely cause(s) of death and whether the deceased
was HIV-positive. There were no specified criteria given
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to the physicians upon which to make the assessment as
to whether the deceased was HIV-positive or not; physi-
cians were allowed the freedom to use their clinical
knowledge of HIV disease presentation. The assessing
physician had access to the respondent’s opinion on the
cause of death. In case of nonagreement between the
two clinicians on whether the deceased was HIV-posi-
tive or not, the opinion of a third, more senior physician
(an internist) was sought. The physicians recorded their
findings on specifically designed verbal autopsy forms.
Sample size
We aimed to assess by verbal autopsy all deaths that
occurred in the study population between 2006 and
2008. No formal sample-size calculations were done.
Statistical methods
Data were double-entered into an MS Access database
(Microsoft Corp., USA) and analyzed using Stata version
10 (Stata Corporation, College Station, Texas, USA).
The analysis of verbal autopsy data was restricted to
deaths in individuals who had participated in at least
one annual census round and so had a valid unique cen-
sus identification number. This identification number
was used to obtain the individual’s HIV serostatus by
linkage with the annual HIV serosurvey results in the
population cohort database. We assessed the perfor-
mance of the verbal autopsy tool in identifying HIV
infection among deaths in adults aged 13 years and
older. Since we did not have data on the actual cause of
death, we defined as “HIV-associated” any death occur-
ring in a person who was HIV-seropositive.
We calculated specificity and positive predictive values
of the verbal autopsy tool, using HIV serostatus as the
gold standard. True positive was defined as HIV-positive
status, and true negative was defined as HIV-negative
status at the last available serosurvey. A verbal autopsy
test positive was defined as an HIV-associated diagnosis
by both assessors, or two out of three assessors in the
case of nonagreement between the first two. A verbal
autopsy test negative was defined as an HIV-negative
diagnosis, or unknown HIV association, by two out of
three assessors. We assessed interobserver agreement
between the first two assessors using a kappa statistic.
We calculated HIV-attributable mortality fraction as the
proportion of deaths of known HIV serostatus that were
classified as “HIV-positive” by verbal autopsy.
Ethical aspects
The study was approved by the Science and Ethics com-
mittee of the Uganda Virus
Research Institute and the Uganda National Council
for Science and Technology. Informants gave written
informed consent prior to participating in the study. A
condolence fee of 5,000 Uganda shillings (US$ 2.20) was
given to each informant.
Results
Between January 2006 and December 2008, there were
387 deaths in the study area among 14,530 adult partici-
pants aged 13 and older in the GPC census and 333
deaths among 12,641 adults with known HIV serostatus
(mortality rate = 10.8 per 1000 person-years, 95% confi-
dence interval (CI): 9.8, 12.1). Among the 333 deaths of
known HIV status, verbal autopsy was done for 264
(79.3%). Of the 69 deaths of known HIV serostatus
where verbal autopsy was not done, in 29 (42%) there
was no relative to interview, in 15 (22%) the relative
refused to be interviewed, and in 25 (36%) no reason
was given.
Of the 333 deaths of known HIV status, a similar pro-
portion of HIV-positive (78.7%) and HIV-negative
(80.1%) deaths were assessed by verbal autopsy
(Table 1). Among the 264 deaths assessed by verbal
autopsy, 59 (22.3%) were HIV-positive and had a mean
(SD) age of 41.0 (14.4) years while 205 (77.7%) were
HIV-negative with a mean (SD) age of 60.1 (22.8) years.
Among all HIV-seropositive deaths in the GPC, there
was no evidence of a difference in mean age between
deaths assessed by verbal autopsy and those that were
not (p = 0.78). However, among the HIV-seronegative
deaths in the GPC, there was some evidence that the
mean age of deaths assessed by verbal autopsy was
greater than that of deaths that were not assessed (61.4
versus 54.9 years, respectively, p = 0.06).
Overall, 68 (25.8%) deaths were classified as HIV-
positive by verbal autopsy. The proportion of deaths
that were classified as HIV-positive decreased with
increasing age: from 50.6% in those aged 13 to 44
years to 5.1% among those aged 65 years and older
(Table 2). Similarly, the proportion of true HIV-sero-
positive deaths decreased with age, from 41.4% of
those aged 13 to 44, to 3.4% of those aged 65 years
and older. The verbal autopsy had an overall specificity
of 90.2% and positive predictive value of 70.6% for
diagnosis of HIV-positive death. In participants aged
13 to 44 years, the corresponding values were 76.5%
and 72.7%, respectively, while among those aged 65
years and over, the values were 96.5% and 33.3%
respectively (Table 3).
The assessors’ agreement as to whether the death was
HIV-positive was found in 212 (80.3%) deaths (kappa
statistic 0.69). The 52 discordant assessments were
evenly distributed between deaths of participants who
were HIV-positive (20.3%) and negative (19.5%) (p =
0.89). The HIV-attributable mortality fraction estimated
by verbal autopsy decreased from 47.0% (pre-ART per-
iod) to 25.8% (ART period) (p < 0.001; Table 4).
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Discussion
In this study population, which has no official vital
registration system, we found that verbal autopsy had an
overall specificity of 90% and positive predictive value of
71% in identifying HIV infection among adult deaths.
Since the introduction of ART in 2004, the prevalence
of HIV infection among adult deaths, as estimated by
verbal autopsy, has reduced, with the HIV-attributable
mortality fraction falling from 47% in the early 1990s to
25.8% in 2006 to 2008.
We found that verbal autopsy performed well in iden-
tifying HIV-positive deaths in the age groups 13 to 44
years and 45 to 64 years. This finding is in agreement
with findings from a study conducted in Tanzania and
Zimbabwe, which showed that, in generalized HIV epi-
demics, verbal autopsy can be used to reliably measure
AIDS mortality, especially in the 15 to 44 year age
group [15]. The positive predictive value of verbal
autopsy is lower among people aged 65 and older than
in the younger age groups because of the lower preva-
lence of HIV-positive deaths. In our study, only 3% of
the deaths in those 65 years and older were HIV-posi-
tive. In contrast, a study in Kenya reported that AIDS
was the principle cause of death among older people up
until the age of 70 years [16]. In populations such as
ours with a lower prevalence of HIV-positive deaths
among people over 65, improved verbal autopsy tools
are needed to reliably measure HIV-positive deaths in
this age group.
In 2006 to 2008, during the time of this verbal
autopsy study, the estimated national ART coverage in
Uganda was 33% [17]. As expected, when compared to
the earlier verbal autopsy study in the period before
ART was introduced in this community [7], we found
Table 1 Total deaths of known HIV serostatus and available verbal autopsy (VA) deaths, by age and HIV status.
Age group (years) VA assessed/total (%)
HIV-positive HIV-negative Deaths known HIV status
13-24 4/7 (57.1%) 19/29 (65.5%) 23/36 (63.9%)
25-34 20/24 (83.3%) 19/22 (86.4%) 39/46 (84.8%)
35-44 12/16 (75.0%) 13/20 (65.0%) 25/36 (69.4%)
45-54 12/13 (92.3%) 12/16 (75.0%) 24/29 (82.8%)
55-64 7/9 (77.8%) 28/36 (77.8%) 35/45 (77.8%)
65+ 4/6 (66.7%) 114/135 (84.4%) 118/141 (83.7%)
Total 59/75 (78.7%) 205/258 (80.1%) 264/333 (79.3%)
Mean (SD) age (years)
VA assessed 41.2 (14.0) 61.4 (22.0) 56.9 (22.1)
Not assessed 40.1 (16.2) 54.9 (25.2) 51.5 (24.2)
All deaths 41.0 (14.4) 60.1 (22.8) 55.8 (22.6)
Table 2 Verbal autopsy classification by age and HIV serostatus.
HIV status by verbal autopsy classification Total (%) True HIV serostatus
HIV-positive HIV-negative
13-44 years Positive 44 (50.6%) 32 12
Negative 32 (36.8%) 2 30
Don’t know 11 (12.6%) 2 9
87 (100%) 36 (41.4%) 51 (58.6%)
45-64 years Positive 18 (30.5%) 14 4
Negative 35 (59.3%) 4 31
Don’t know 6 (10.2%) 1 5
59 (100%) 19 (32.2%) 40 (67.8%)
65+ years Positive 6 (5.1%) 2 4
Negative 103 (87.3%) 1 102
Don’t know 9 (7.6%) 1 8
118 (100%) 4 (3.4%) 114 (96.6%)
All ages Positive 68 (25.8%) 48 20
Negative 170 (64.4%) 7 163
Don’t know 26 (9.8%) 4 22
Total deaths 264 (100%) 59 (22.3%) 205 (77.7%)
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a decline in the proportion of deaths that were HIV-
positive. Our estimated HIV-attributable mortality
fraction from the verbal autopsy data is somewhat
higher than that estimated from the main GPC cohort
based on HIV serostatus (25.8% versus 17.0%). The
observed decline in HIV-attributable mortality fraction
since the early 1990s reflects improved clinical care
and cotrimoxazole prophylaxis before ART was avail-
able, as well as the introduction of ART in 2004. The
impact of ART in reducing HIV-associated mortality
has been documented before [18-20]. Access to ART
has improved the survival of HIV-infected individuals,
making HIV infection a chronic manageable disease
and allowing these individuals to live socially- and eco-
nomically-active lives [21]. Although worldwide the
number of people living with HIV increased from 29
million in 2001 to 33.4 million in 2008, HIV-associated
deaths increased only from 1.9 million to 2 million
over the same period [18]. We assessed a higher pro-
portion of all adult deaths by verbal autopsy than was
done in the 1990-1993 study. However, in both studies,
there was no difference by HIV status in the
proportion of deaths assessed. Therefore, our observed
decrease in the estimated HIV-attributable fraction is
unlikely to be a result of HIV-positive selection bias in
the verbal autopsy assessed deaths.
In this study we used two physicians to review and
independently ascertain whether the deceased was
HIV-positive or not, and a tie-breaker third clinician
in case of nonagreement. There has been debate as to
which is the best method to use to ascertain the cause
of death from verbal autopsy questionnaires in
resource-limited settings. Though physician review of
verbal autopsy questionnaires is the most commonly
used method, issues have been raised about the possi-
ble inter- and intra-observer variability, the demands
on physicians’ time, and the remuneration costs of
these physicians [22,23]. Other techniques like the
probabilistic (InterVA) model [24,25], symptom pattern
[26], machine learning, and tariff method have been
developed and validated, but a universally accepted
method is yet to be decided.
The assessing clinicians’ ascertainment of whether the
deceased was HIV-positive could have been biased by
the opinion of the deceased’s relative. Without access to
this information, the performance of the verbal autopsy
tool may have been lower, and our results may not be
generalizable to settings where the respondent’s opinion
was not available. However, the majority of deaths in
our cohort occurred at home or outside health care
facilities without medical attention, and so the responses
of caregivers and relatives may reflect general awareness
of HIV and recognition of its symptoms in the commu-
nity. Thus our results may be generalizable to other
rural settings with similar HIV prevalence, in which ver-
bal autopsy information is obtained from family
members.
This study had several strengths. The annual HIV
survey allowed the HIV serostatus of the majority of
deaths to be known. The monthly reports of deaths in
the area by the community-based recorders allowed us
to have a fairly complete death registration. We
ensured consistency in the interviewing process by
Table 3 Performance of the verbal autopsy tool using HIV serostatus as gold standard, by age group
Age group (years)
13-44 45-64 65+ All ages
Specificity (95% CI) 76.5% (62.5-87.2%) 90.0% (76.3-97.2%) 96.5% (91.3-99.0%) 90.2% (85.3-93.9%)
Positive predictive value (95% CI) 72.7% (57.2-85.0%) 77.8% (52.4-93.6%) 33.3% (4.3-77.7%) 70.6% (58.3-81.0%)
HIV-attributable mortality fraction (95% CI)
this study 50.6% (39.6-61.5%) 30.5% (19.2-43.9%) 5.1% (1.9-10.7%) 25.8% (20.6-31.5%)
cohort (based on ALPHA data2) 40.3% 24.4% 1.6% 17.0%
1Test (verbal autopsy) positive defined as positive by both assessors, or by 2 out of 3 assessors in case of nonagreement; test negative defined as negative or
unknown by both assessors, or by 2 out of 3 assessors in case of nonagreement.
2Unpublished Analysing Longitudinal Population-based HIV cohorts in Africa (ALPHA) data
Table 4 Comparison of verbal autopsy-assessed HIV-
associated deaths in pre-ART and ART periods.
Characteristics Verbal autopsy study
period
Study period Pre-ART
(1990-93)
ART
(2006-08)
HIV prevalence 8.0% 7.5%
Deaths of known HIV serostatus 293 333
Deaths where verbal autopsy was done 155 (53%) 264 (79%)
HIV-positive deaths with verbal autopsy 78 (50%) 59 (22%)
Specificity 92% 90%
Positive predictive value 92% 71%
Assessors’ agreement on HIV-associated deaths 91% 80%
Kappa statistic n/a 0.69
HIV-attributable mortality fraction-VA study 47% 25.8%
HIV-attributable mortality fraction-cohort data 50% 17%
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using the same interviewer for all the relatives of the
deceased. The use of the same questionnaire as in the
previous study enabled comparison of the findings of
the two studies. There was substantial interobserver
agreement between the two assessing clinicians and
verbal autopsy had good specificity and positive predic-
tive value for the identification of HIV-positive deaths.
The two-month interval between death and the verbal
autopsy interview likely minimized any difficulty parti-
cipants had in recalling the circumstances of their
loved ones’ deaths and minimized the stress caused by
the verbal autopsy interview, resulting in a high parti-
cipation rate.
Our study limitations included the fact that some of
the censused GPC participants had not participated in
the annual HIV serosurvey and therefore had no HIV
test results and were excluded from analysis. Further-
more, some individuals may not have participated in a
recent serosurvey and thus may have seroconverted
since their last negative HIV test. However, the HIV
incidence in this population is relatively low (4.3, 95%
CI: 3.6, 5.1 per 1,000 person-years; unpublished data),
so any misclassification bias is likely to be small. We
also could not carry out verbal autopsy for all the
deceased participants as some relatives refused to be
interviewed and, in other cases, there were no relatives
to interview. Using HIV status (instead of the actual
cause of death) as the comparison gold standard for
HIV-associated deaths may not be ideal, as some HIV-
infected participants might have died of other non-
HIV-related causes.
Conclusions
The good specificity and positive predictive value of ver-
bal autopsy in this study in identifying deaths in HIV-
positive persons in a resource-limited setting with lim-
ited official vital registration systems adds to the evi-
dence of the value of verbal autopsy in determining
HIV-positive deaths. Policymakers should consider ver-
bal autopsy as a source of information about deaths
occurring among HIV-positive individuals and HIV-
associated deaths that can be added in routine health
information systems.
Appendix
Items included in ART period (2006 - 2008) verbal
autopsy study questionnaire.
General
•Where death occurred
• Any spouse of the deceased died in the last 5 years,
if so, believed cause of death
• Respondent’s detailed account of illness
Circumstances of death
• Duration of terminal illness
• Was death sudden and unexpected
• Type of medical treatment during the last 3
months before death
• Whether deceased was on ART, and if yes, when
ART was started
• Ever treated for tuberculosis
• Health unit(s) attended
• Records available in home (extract findings)
Signs, symptoms and their severity
during the last illness
• Fever
• Diarrhea
• Dehydration
• Vomiting/associated abdominal pain
• Breathing (chest pain/chest in-drawing/difficult/
rapid/wheezing)
• Cough (severe/productive/blood in sputum/fol-
lowed by vomiting)
Neurological
• Neck stiffness
• Unconscious
• Fits (jerking of whole body/individual limbs/fre-
quency per day)
• History of epileptic illness in earlier years
• Paralysis of limbs
• Rigid body stiffness, unable to open mouth
Others
• Skin rash and itching
• Red and sore eyes
• Loss of weight
• Abscesses/body sores
• Body swelling (edema/which parts)
• Constipation (associated abdominal pain)
• Hair changes (light colored or thin)
• Yellowing of eyes/passing brown urine
• Herpes zoster (at any time in life)
Respondent’s opinion of cause of death
• Specify
• How or from whom did you know
Interviewer’s diagnosis
• Illness 1
• Illness 2
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Final classification (Clinician)
• Death HIV-related
• Death ART-related
• Leading cause of death
• Subsidiary causes
List of abbreviations
ART: antiretroviral therapy; GPC: general population cohort
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